Future investigations into the molecular mechanisms underlying SWELL1 function will deepen our understanding of liver lipid metabolism disorders and pave the way for developing novel SWELL1-targeted therapies. This evidence concerns the gene LRRC8A and Disorder of lipid metabolism.